Sigma-1 receptor ligand PD144418 and sigma-2 receptor ligand YUN-252 attenuate the stimulant effects of methamphetamine in mice
Previous research indicates that the selective sigma-1 receptor ligand PD144418 and the selective sigma-2 ligands YUN-252 can inhibit cocaine-induced hyperactivity. The effects of these ligands on other stimulants, such as methamphetamine, have not been reported.
The present study examined the effects of PD144418 and YUN-252 pretreatment on methamphetamine-induced hyperactivity after acute treatment.
Mice (n = 8–14/group) were injected with PD144418 (3.16, 10, or 31.6 μmol/kg), YUN-252 (0.316, 3.16, 31.6 μmol/kg), or saline. After 15 min, mice injected with 2.69 μmol/kg methamphetamine or saline vehicle, where distance traveled during a 60-min period was recorded. Additionally, the effect of PD144418 on the initiation and expression of methamphetamine sensitization was determined by treating mice (n = 8–14/group) with PD144418, methamphetamine or saline repeatedly over a 5-day period, and testing said mice with a challenge dose after a 7-day withdrawal period.
Results indicate that both PD144418 and YUN-252, in a dose-dependent manner, attenuated hyperactivity induced by an acute methamphetamine injection. Specifically, 10 μmol/kg or 31.6 μmol/kg of PD144418 and 31 μmol/kg of YUN-252 suppressed methamphetamine-induced hyperactivity. In regard to methamphetamine sensitization, while 10 μmol/kg PD144418 prevented the initiation of methamphetamine sensitization, it did not have an effect on the expression.
Overall, the current results suggest an intriguing potential for this novel sigma receptor ligand as a treatment for the addictive properties of methamphetamine. Future analysis of this novel sigma receptor ligand in assays directly measuring reinforcement properties will be critical.
KeywordsSigma receptor Methamphetamine Locomotor activity
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Blasio A, Valenza M, Iyer MR, Rice KC, Steardo L, Hayashi T, Cottone P, Sabino V (2015) Sigma-1 receptor mediates acquisition of alcohol drinking and seeking behavior in alcohol-preferring rats. Behav Brain Res 287:315–322. https://doi.org/10.1016/j.bbr.2015.03.065 CrossRefPubMedPubMedCentralGoogle Scholar
- Hayashi T, Justinova Z, Hayashi E, Cormaci G, Mori T, Tsai SY, Barnes C, Goldberg SR, Su TP (2010) Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats. J Pharmacol Exp Ther 332:1054–1063. https://doi.org/10.1124/jpet.109.159244 CrossRefPubMedPubMedCentralGoogle Scholar
- Katz JL, Hiranita T, Kopajtic TA, Rice KC, Mesangeau C, Narayanan S, Abdelazeem AH, McCurdy CR (2016) Blockade of cocaine or sigma receptor agonist self administration by subtype-selective sigma receptor antagonists. J Pharmacol Exp Ther 358:109–124. https://doi.org/10.1124/jpet.116.232728 CrossRefPubMedPubMedCentralGoogle Scholar
- Kaushal N, Robson MJ, Vinnakota H, Narayanan S, Avery BA, McCurdy CR, Matsumoto RR (2011) Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents. AAPS J 13:336–346. https://doi.org/10.1208/s12248-011-9274-9 CrossRefPubMedPubMedCentralGoogle Scholar
- Klawonn AM, Nilsson A, Rådberg CF, Lindström SH, Ericson M, Granseth B, Engblom D, Fritz M (2017) The Sigma-2 receptor selective agonist Siramesine (Lu 28-179) decreases cocaine-reinforced Pavlovian learning and alters glutamatergic and dopaminergic input to the striatum. Front Pharmacol 8:714. https://doi.org/10.3389/fphar.2017.00714 CrossRefPubMedPubMedCentralGoogle Scholar
- Lever JR, Miller DK, Fergason-Cantrell EA, Green CL, Watkinson LD, Carmack TL, Lever SZ (2014) Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418. J Pharmacol Exp Ther 351:153–163. https://doi.org/10.1124/jpet.114.216671 CrossRefPubMedPubMedCentralGoogle Scholar
- Martin-Fardon R, Maurice T, Aujla H, Bowen WD, Weiss F (2007) Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Neuropsychopharmacology 32:1967–1973. https://doi.org/10.1038/sj.npp.1301323 CrossRefPubMedGoogle Scholar
- Matsumoto RR, Shaikh J, Wilson LL, Vedam S, Coop A (2008) Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: evidence from in vivo and in vitro studies. Eur Neuropsychopharmacol 18:871–881. https://doi.org/10.1016/j.euroneuro.2008.07.006 CrossRefPubMedPubMedCentralGoogle Scholar
- Navarro G, Moreno E, Aymerich M, Marcellino D, McCormick PJ, Mallol J, Cortes A, Casado V, Canela EI, Ortiz J, Fuxe K, Lluis C, Ferre S, Franco R (2010) Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci U S A 107:18676–18681. https://doi.org/10.1073/pnas.1008911107 CrossRefPubMedPubMedCentralGoogle Scholar
- Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Yamamori H, Umeda-Yano S, Kamino K, Ikezawa K, Azechi M, Iwase M, Kazui H, Kasai K, Takeda M (2011) The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex. Prog Neuro-Psychopharmacol Biol Psychiatry 35:1309–1315. https://doi.org/10.1016/j.pnpbp.2011.04.008 CrossRefGoogle Scholar
- Rodvelt KR, Lever SZ, Lever JR, Blount LR, Fan KH, Miller DK (2011) SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus. Pharmacol Biochem Behav 97:676–682. https://doi.org/10.1016/j.pbb.2010.11.016 CrossRefPubMedGoogle Scholar
- Sabino V, Cottone P, Zhao Y, Iyer MR, Steardo L, Steardo L, Rice KC, Conti B, Koob GF, Zorrilla EP (2009b) The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking. Neuropsychopharmacology 34:1482–1493. https://doi.org/10.1038/npp.2008.192 CrossRefPubMedGoogle Scholar
- Sabino V, Cottone P, Blasio A, Iyer MR, Steardo L, Rice KC, Conti B, Koob GF, Zorrilla EP (2011) Activation of sigma-receptors induces binge-like drinking in Sardinian alcohol-preferring rats. Neuropsychopharmacology 36:1207–1218. https://doi.org/10.1038/npp.2011.5 CrossRefPubMedPubMedCentralGoogle Scholar
- Sage AS, Oelrichs CE, Davis DC, Fan KH, Nahas RI, Lever SZ, Lever JR, Miller DK (2013) Effects of N-phenylpropyl-N'-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice. Pharmacol Biochem Behav 110:201–207. https://doi.org/10.1016/j.pbb.2013.07.006 CrossRefPubMedGoogle Scholar
- Sambo DO, Lin M, Owens A, Lebowitz JJ, Richardson B, Jagnarine DA, Shetty M, Rodriquez M, Alonge T, Ali M, Katz J, Yan L, Febo M, Henry LK, Bruijnzeel AW, Daws L, Khoshbouei H (2017) The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nat Commun 8:2228. https://doi.org/10.1038/s41467-017-02087-x CrossRefPubMedPubMedCentralGoogle Scholar
- Scott LL, Sahn JJ, Ferragud A, Yen RC, Satarasinghe PN, Wood MD, Hodges TR, Shi T, Prakash BA, Friese KM, Shen A, Sabino V, Pierce JT, Martin SF (2018) Small molecule modulators of sigma2R/Tmem97 reduce alcohol withdrawal-induced behaviors. Neuropsychopharmacology 43:1867–1875. https://doi.org/10.1038/s41386-018-0067-z CrossRefPubMedPubMedCentralGoogle Scholar
- Xu YT, Kaushal N, Shaikh J, Wilson LL, Mesangeau C, McCurdy CR, Matsumoto RR (2010) A novel substituted piperazine, CM156, attenuates the stimulant and toxic effects of cocaine in mice. J Pharmacol Exp Ther 333:491–500. https://doi.org/10.1124/jpet.109.161398 CrossRefPubMedPubMedCentralGoogle Scholar